Replies to post #170973 on Biotech Values

[binchey]

Thanks Peter, we know that there is a meeting between FDA and ARia. Assuming potentially positive impact of all this favorable data, i wonder how fast iclusig can return to the market in your opinion? Do you think FDA might require additional trial data with lowered dose?

[jq1234]

Do you have the 1st line trial poster?

[ilpapa]

Also interesting that the MD Andersen front line trial shows not a hint of cardiovascular issues

That hardly seems possible, does it?